Alcohol effects on liver diseases: Good or bad buddy?

Annals of Hepatology

Volumn 11, Issue 6, 2012, Pages 944-948

  Barbero Becerra, Varenka J ^a   López Velázquez, Jorge A ^a   Sánchez Valle, Vicente ^a   Uribe, Misael ^a   Méndez Sánchez, Nahum ^a  

^a LIVER RESEARCH UNIT   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALANINE AMINOTRANSFERASE; ALCOHOL; ALCOHOL DEHYDROGENASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; CYTOCHROME P450 2E1; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; HYDROGEN PEROXIDE; INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; CHRONIC LIVER DISEASE; DRUG RESPONSE; EDITORIAL; HEPATITIS B; HEPATITIS C; HUMAN; LIVER DISEASE; LIVER INJURY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; RISK FACTOR;

EID: 84869429826     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31422-x     Document Type: Editorial

References (40)

1. Seth D, Haber PS, Syn WK, Diehl AM, Day CP. Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances. J Gastroenterol Hepatol 2011; 26: 1089-105.
2. Oshita M, Hayashi N, Kasahaela N, Hagiwaeu H, Mita E, Naito M, Katayama K, et al. Increased Serum Hepatitis C Virus RNA Levels Among Alcoholic Patients with Chronic Hepatitis C. Hepatology 1994; 20: 1115-20.
3. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Tee-rawattananon Y, Patra J. Global burden of disease and in-jury and economic cost attributable to alcohol use and al-cohol-use disorders. Lancet 2009; 373: 2223-33.
4. Tome S, Lucey M. Review article: current management of alcoholic liver disease. Aliment. Pharmacol Ther 2004; 19: 707-14.
5. Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M, McCullough AJ, Schwimmer JB. Modest alcohol consumption is associated with decreased prevalence of steatohepati-tis in patients with non-alcoholic fatty liver disease (NA-FLD). J Hepatol 2012; 57: 384-39.
6. Pessione F, Degos FO, Marcellin P, Duchatelle V, Njapoum C, Martinot PM, Degott C, et al. Effect of Alcohol Consumption on Serum Hepatitis C Virus RNA and Histological Lesions in Chronic Hepatitis C. Hepatology 1998;27:1717-22.
7. Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ. Chronic he-patitis C: effect of alcohol on hepatitic activity and viral titre. J Hepatol 1996; 25: 821-6.
8. Balasubramanian S, Kowdley K. Effect of Alcohol on Viral Hepatitis and Other Forms of Liver Dysfunction. Clin Li-ver Dis 2005; 9: 83-101.
9. Nomura H, Hayashi J, Kajiyama W, Kashiwagi S. Alcohol consumption and seroconversion from hepatitis B e anti-gen in the Okinawa Japanese. Fukuoka Igaku Zasshi 1996; 87: 237-41.
10. Wiley TE, McCarthy M, Breidi L, McCarthy M, Layden TJ. Impact of Alcohol on the Histological and Clinical Progression of Hepatitis C Infection. Hepatology 1998; 28: 805-09.
11. Mello T, Ceni E, Surrenti C, Galli A. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol Aspects Med 2008; 29: 17-21.
12. Niemela O. Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radic Biol Med 2001; 31: 1533-8.
13. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001; 35: 297-306.
14. Mato JM, Camara J, Fernandez de Paz J, Caballería L, Coll S, Caballero A, García-Buey L, et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-contro-lled, double-blind, multicenter clinical trial. J Hepatol 1999: 30: 1081-9.
15. Kendrick SF, O'Boyle G, Mann J, Zeybel M, Palmer J, Jones DE, Day CP. Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology 2010; 51: 1988-97.
16. Alisi A, Ghidinelli M, Zerbini A, Missale G, Balsano C. Hepati-tis C virus and alcohol: same mitotic targets but different signaling pathways. J Hepatol 2011; 54: 956-63.
17. Mas VR, Fassnacht R, Archer KJ, Maluf D. Molecular mecha-nisms involved in the interaction effects of alcohol and he-patitis C virus in liver cirrhosis. Mol Med 2010; 16: 287-97.
18. Dey A, Cederbaum AI. Alcohol and oxidative liver injury. Hepatology 2006; 43: S63-S74.
19. Suzuki A, Angulo P, St. Sauver J, Muto A, Okada T, Lindor K. Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gas-troenterol 2007; 102: 1912-9.
20. Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty li-ver disease. Hepatology 2008; 47: 1947-54.
21. Anand BS, Thornby J. Alcohol has no effect on hepatitis C virus replication: a meta-analysis. Gut 2005; 54: 1468-72.
22. Ekstedt M, Franzén LE, Holmqvist M, Bendtsen P, Mathie-sen UL, Bodemar G, Kechagias S. Alcohol consumption is associated with progression of hepatic fibrosis in non-al-coholic fatty liver disease. Scand J Gastroenterol 2009; 44: 366-74.
23. Westin J, Lagging LM, Spak F, Aires N, Svensson E, Lindh M, Dhillon AP, et al. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepatitis 2002; 9: 235-41.
24. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria L, et al. Drinking habits as cofac-tors of risk for alcohol induced liver damage. Gut 1997; 41: 845-50.
25. Gronbaek M, Jensen MK, Johansen D, Sorensen T, Bec-ker U. Intake of Beer, Wine and Spirits and Risk of Hea-vy Drinking and Alcoholic Cirrhosis. Biol Res 2004; 37: 195-200.
26. Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 2003; 37: 544-50.
27. Ruhl CE, Everhart JE. Joint Effects of Body Weight and Al-cohol on Elevated Serum Alanine Aminotransferase in the United States Population. Clinical Gastroenterology and Hepatology 2005; 3: 1260-8.
28. Elmadhun NY, Lassaletta AD, Chu LM. Vodka and wine con-sumption in a swine model of metabolic syndrome alters in-sulin signaling pathways in the liver and skeletal muscle. Surgery 2012; 152: 414-22.
29. Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Ta-ylor PR. Effects of moderate alcohol intake on fasting in-sulin and glucose concentration and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA 2002; 287: 2559-62.
30. Bonnet F, Disse E, Laville M, Mari A, Hojlund K, An-derwald CH, Piatti P, et al. Moderate alcohol con-sumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy wo-men. Diabetologia 2012.
31. Wannamethee SG, Camargo CA, Manson JE, Willet WC, Rimm EB. Al cohol drinking patterns and risk of type 2 dia-betes mellitus among younger women. Arch Intern Med 2003; 163: 1329-36.
32. Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med 2004; 140: 211-9.
33. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010; 52: 1156-61.
34. Liangpunsakul S, Chalasani N. What Should We Recommend to Our Patients with NAFLD Regarding Alcohol Use? Am J Gastroenterol 2012; 107: 976-8.
35. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Ia-coviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 pros-pective studies. Arch Intern Med 2006; 166: 2437-45.
36. Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW Jr, Doll R. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997; 337: 1705-14.
37. O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver di-sease. Hepatology 2010; 51: 307-28.
38. Tsukamoto H, Machida K, Dynnyk A, Mkrtchyan H. "Se-cond hit" models of alcoholic liver disease. Semin Liver Dis 2009; 29: 178-87.
39. De Alwis WNM, Day CP. Genetics of alcoholic liver disease and no-nalcoholic fatty liver disease. Semin Liver Dis 2007; 27: 44-54.
40. Gao B, Bataller R. Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets. Gastroenterology 2011; 141: 1572-85.